Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly : awareness warranted for 2017/18 season

Rondy, Marc ; Gherasim, Alin ; Casado, Itziar ; Launay, Odile ; Rizzo, Caterina ; Pitigoi, Daniela ; Mickiene, Aukse ; Marbus, Sierk D ; Machado, Ausenda and Syrjänen, Ritva K , et al. (2017) In Eurosurveillance 22(41).
Abstract

In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65-79-year-olds and 13% (95% CI: -15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.

Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
contributor
LU orcid
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adolescent, Adult, Aged, European Union, Female, Hospitalization/statistics & numerical data, Hospitals, Humans, Influenza A Virus, H3N2 Subtype/immunology, Influenza Vaccines/immunology, Influenza, Human/epidemiology, Male, Middle Aged, Outcome Assessment (Health Care), Seasons
in
Eurosurveillance
volume
22
issue
41
publisher
European Centre for Disease Prevention and Control (ECDC)
external identifiers
  • scopus:85031997178
  • pmid:29043961
ISSN
1560-7917
DOI
10.2807/1560-7917.ES.2017.22.41.17-00645
project
Infectious diseases surveillance, vaccine effectiveness and determinants of acceptance
language
English
LU publication?
yes
id
0a50a0fd-8f00-4bc6-bc77-17fd8ce06b8d
date added to LUP
2019-04-23 10:10:28
date last changed
2024-02-14 22:02:21
@article{0a50a0fd-8f00-4bc6-bc77-17fd8ce06b8d,
  abstract     = {{<p>In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65-79-year-olds and 13% (95% CI: -15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.</p>}},
  author       = {{Rondy, Marc and Gherasim, Alin and Casado, Itziar and Launay, Odile and Rizzo, Caterina and Pitigoi, Daniela and Mickiene, Aukse and Marbus, Sierk D and Machado, Ausenda and Syrjänen, Ritva K and Pem-Novose, Iva and Horváth, Judith Krisztina and Larrauri, Amparo and Castilla, Jesús and Vanhems, Philippe and Alfonsi, Valeria and Ivanciuc, Alina E and Kuliese, Monika and van Gageldonk-Lafeber, Rianne and Gomez, Veronica and Ikonen, Niina and Lovric, Zvjezdana and Ferenczi, Annamária and Moren, Alain}},
  issn         = {{1560-7917}},
  keywords     = {{Adolescent; Adult; Aged; European Union; Female; Hospitalization/statistics & numerical data; Hospitals; Humans; Influenza A Virus, H3N2 Subtype/immunology; Influenza Vaccines/immunology; Influenza, Human/epidemiology; Male; Middle Aged; Outcome Assessment (Health Care); Seasons}},
  language     = {{eng}},
  number       = {{41}},
  publisher    = {{European Centre for Disease Prevention and Control (ECDC)}},
  series       = {{Eurosurveillance}},
  title        = {{Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly : awareness warranted for 2017/18 season}},
  url          = {{http://dx.doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645}},
  doi          = {{10.2807/1560-7917.ES.2017.22.41.17-00645}},
  volume       = {{22}},
  year         = {{2017}},
}